Ardelyx reported $-28071000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbott ABT:US $ 2447M 458M
Amgen AMGN:US $ 1476M 423M
Ardelyx ARDX:US $ -28.07M 8.16M
Astrazeneca AZN:US $ 386M 733M
Biocept BIOC:US $ -2.77M 0.2M
Chimerix CMRX:US $ -24.77M 14.73M
Corcept Therapeutics CORT:US $ 22.8M 9.26M
Curis CRIS:US $ -16.11M 2.49M
Life Technologies LIFE:US $ -12.15M 3.59M
Opko Health OPK:US $ -55.43M 18.34M
Tg Therapeutics TGTX:US $ -69.01M 24.32M
United Therapeutics UTHR:US $ 239.9M 127.7M
Xoma XOMA:US $ -2280000 32.12M